The revelation that mutations in the MAPT gene that encodes Tau can cause neuronal dysfunction, cognitive impairment and death in frontotemporal dementia (FTD) and PSP sufferers supported the importance of tauopathy as a significant class of NDDs [30,32]. The gene discussed is MAPT; the disease is tauopathy.